CAMP vs CBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CBIO Captures Institutional Edge (2โ1 Pillars ยท 3โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Crescent Biopharma, Inc. Common Stock (CBIO) driven by superior Momentum & Technical, Options & Structure while CAMP counters with relative strength in Growth & Margin. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus CBIO at N/M Forward P/E and -1228.4% operating margin (+0.0% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CBIO sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAMP Revenue | CBIO Revenue | CAMP Op. Margin | CBIO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2015 | N/A | $20M | N/A | -63.7% | CBIO |
| FY2016 | N/A | $0M | N/A | -172505.3% | CBIO |
| FY2020 | N/A | $10M | N/A | -506.8% | CBIO |
| FY2021 | N/A | $0M | N/A | -5470.7% | CBIO |
| FY2022 | N/A | $0M | N/A | -63204.4% | CBIO |
| FY2023 | $0M | $0M | -14822.6% | -392752.9% | CAMP |
| FY2024 | $0M | N/A | -8142.3% | N/A | CAMP |
| FY2025 | $0M | $10M | -1502.4% | -1407.5% | CBIO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAMP | CBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.5M | $591.3M | Larger Scale | CBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +138.9% | +0.0% | Higher Growth | CAMP |
| Operating Margin (TTM) Profitability | -991.8% | -1228.4% | Higher Margin | CAMP |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -146.1% | -160.8% | Higher ROE | CAMP |
| 52-Week Range Position Momentum | 22% ($3โ$8) | 24% ($9โ$27) | Stronger Trend | CBIO |
| Beta / 30D Volatility Risk Regime | 1.34ฮฒ ยท 94% Vol | 1.38ฮฒ ยท 58% Vol | Lower Realized Risk | CBIO |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 42.4 / 100 (HOLD) | Higher Composite | CAMP |